China Kanghui Holdings, which is a leading China-based manufacturer and marketer of orthopedic implants, filed on Friday with the SEC to raise up to $75 million in an initial public offering. The Changzhou-based company, which was founded in 1997 and booked $29 million in sales over the last 12 months, plans to list on the NYSE under the symbol KH. Morgan Stanley and Piper Jaffray are the lead underwriters on the deal. No pricing terms were disclosed.
Spineway: 2020 Revenue Confirmed Upturn in Activity for the 4th Quarter of 2020, Good Performance in Asia: +19%
January 14, 2021
January 12, 2021